Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Neoplasms 5Glioblastoma 4Lung Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Glioma 2Colorectal Neoplasms 2Breast Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Prostatic Neoplasms 1Pleural Neoplasms 1Pancreatic Cyst 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Mesothelioma 1Medication Adherence 1Margins of Excision 1Lymphedema 1Lung Diseases 1Liver Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Temozolomide 162Radiosurgery 114Radiotherapy 99Bevacizumab 95Magnetic Resonance Spectroscopy 64Carboplatin 48Etoposide 34Surgical Procedures, Operative 33Irinotecan 33pembrolizumab 32Nivolumab 32Cyclophosphamide 32Erlotinib Hydrochloride 31Radiation 29Carmustine 28Cisplatin 25Lomustine 24Trastuzumab 23Ipilimumab 23Filgrastim 23Vincristine 20Mental Status and Dementia Tests 20Aminolevulinic Acid 19Topotecan 18Pemetrexed 18Capecitabine 18Specimen Handling 17Sorafenib 15Radiotherapy, Intensity-Modulated 15Imatinib Mesylate 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Brain Neoplasms × Drug Delivery Systems × Clear all
NCT05733312 2026-01-30

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Mayo Clinic

Phase NA Recruiting
6 enrolled
CNS

Brain Neoplasms

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT00431561 2013-12-03

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Isarna Therapeutics GmbH

Phase 2 Completed
141 enrolled
CNS

Astrocytoma, Brain Neoplasms, Camurati-Engelmann Syndrome, Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡